Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Condensed Consolidated Statements of Operations and Comprehensive Loss    
Sales $ 318,800  
Cost of sales 223,668  
Gross profit 95,132  
Operating expenses:    
Selling, general and administrative expenses 297,272 $ 231,227
Amortization expense 357,463 357,324
Transaction costs 968,505 168,445
Total operating expenses 1,623,240 756,996
Operating loss (1,528,108) (756,996)
Other expenses:    
Investment and other income (expense) (5,144)  
Interest and other expense (350,382) (311,413)
Other expense, net (355,526) (311,413)
Operating loss before income taxes (1,883,634) (1,068,409)
Net loss (1,883,634) (1,068,409)
Other comprehensive loss, net of tax:    
Unrealized loss on available-for-sale securities (17,067)  
Total other comprehensive loss (17,067)  
Comprehensive loss $ (1,900,701) $ (1,068,409)
Basic net loss per share: $ (0.58) $ (0.35)
Diluted net loss per share: $ (0.58) $ (0.35)
Weighted Average Basic Shares Outstanding 3,231,461 3,074,998
Weighted Average Dilutive Shares Outstanding 3,231,461 3,074,998